Molecular mechanisms underlying Ca2+-mediated motility of human pancreatic duct cells

American Journal of Physiology - Cell Physiology

Volumn 299, Issue 6, 2010, Pages

  Dong, Hui ^a   Shim, Ki Nam ^e   Li, Jenny M J ^a   Estrema, Christine ^a   Ornelas, Tiffany A ^a   Nguyen, Flang ^a   Liu, Shanglei ^a   Ramamoorthy, Sonia L ^f   Ho, Samuel ^c   Carethers, John M ^a,b,c,d   Chow, Jimmy Y C ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e Ewha Womans University School of Medicine   (South Korea)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Pancreatic cancer; Sodium calcium exchanger; Transforming growth factor beta; Transient receptor potential canonical

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; 2 AMINOETHOXYDIPHENYLBORANE; CALCIUM CHANNEL; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MEMBRANE PROTEIN; SMALL INTERFERING RNA; SODIUM CALCIUM EXCHANGE PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CANCER CELL; CANCER INVASION; CELL MOTILITY; HOMEOSTASIS; HUMAN; HUMAN CELL; MEMBRANE TRANSPORT; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

BORON COMPOUNDS; CALCIUM; CARBAZOLES; CELL LINE; CELL MOVEMENT; ENZYME INHIBITORS; HOMEOSTASIS; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROTEIN KINASE C-ALPHA; SODIUM-CALCIUM EXCHANGER; THIOUREA; TRANSFORMING GROWTH FACTOR BETA; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

MAMMALIA;

EID: 78649675903     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00242.2010     Document Type: Article

References (63)

1. Abramowitz J, Birnbaumer L. Physiology and pathophysiology of canonical transient receptor potential channels. FASEB J 23: 297-328, 2009.
2. 2+ entry in endothelial cells. J Biol Chem 279: 20941-20949, 2004.
3. 2+ channels and regulation of calcium microdomains. Cell Calcium 40: 495-504, 2006.
4. 2+ exchanger in rat pancreatic ducts. J Membr Biol 186: 43-53, 2002.
5. Attisano L, Wrana JL. Mads and Smads in TGF beta signalling. Curr Opin Cell Biol 10: 188-194, 1998.
6. Blaustein MP, Lederer WJ. Sodium/calcium exchange: its physiological implications. Physiol Rev 79: 763-854, 1999.
7. Bödding M, Wissenbach U, Flockerzi V. Characterisation of TRPM8 as a pharmacophore receptor. Cell Calcium 42: 618-628, 2007.
8. Brini M, Carafoli E. Calcium pumps in health and disease. Physiol Rev 89: 1341-1378, 2009.
9. Caldas C, Kern SE. K-ras mutation and pancreatic adenocarcinoma. Int J Pancreatol 18: 1-6, 1995.
10. Chow JY, Quach KT, Cabrera BL, Cabral JA, Beck SE, Carethers JM. RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells. Carcinogenesis 28: 2321-2327, 2007.
11. Chow JYC, Dong H, Quach KT, Van Nguyen PN, Chen K, Carethers JM. TGF-beta mediates PTEN suppression and cell motility through calcium-dependent PKC-alpha activation in pancreatic cancer cells. Am J Physiol Gastrointest Liver Physiol 294: G899-G905, 2008.
12. - secretion in mice. Am J Physiol Gastrointest Liver Physiol 288: G457-G465, 2005.
13. 2+ signaling in duodenocytes and contribute to duodenal mucosal bicarbonate secretion. Am J Physiol Gastrointest Liver Physiol 296: G424-G432, 2009.
14. Fogh J, Wright WC, Loveless JD. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J Natl Cancer Inst 58: 209-214, 1977.
15. Frey RS, Mulder KM. TGFbeta regulation of mitogen-activated protein kinases in human breast cancer cells. Cancer Lett 117: 41-50, 1997. (Pubitemid 27322913)
16. Furukawa T, Sunamura M, Horii A. Molecular mechanisms of pancreatic carcinogenesis. Cancer Sci 97: 1-7, 2006.
17. Gold MG, Barford D, Komander D. Lining the pockets of kinases and phosphatases. Curr Opin Struct Biol 16: 693-701, 2006.
18. Gunji N, Oda T, Todoroki T, Kanazawa N, Kawamoto T, Yuzawa K, Scarpa A, Fukao K. Pancreatic carcinoma: correlation between E-cadherin and alpha-catenin expression status and liver metastasis. Cancer 82: 1649-1656, 1998.
19. Hahn SA, Hoque AT, Moskaluk CA, da Costa LT, Schutte M, Rozenblum E, Seymour AB, Weinstein CL, Yeo CJ, Hruban RH, Kern SE. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 56: 490-494, 1996.
20. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353, 1996.
21. 2+. Cell Physiol Biochem 23: 387-396, 2009.
22. Hartsough MT, Mulder KM. Transforming growth factor beta activation of p44mapk in proliferating cultures of epithelial cells. J Biol Chem 270: 7117-7124, 1995.
23. Howe HL, Wu X, Ries LA, Cokkinides V, Ahmed F, Jemal A, Miller B, Williams M, Ward E, Wingo PA, Ramirez A, Edwards BK. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 107: 1711-1742, 2006.
24. 2+ loading in neonatal rabbit cardiac ventricular myocytes. Am J Physiol Cell Physiol 290: C1572-C1582, 2006.
25. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
26. 2+ entry in U937 monocytes. J Pharmacol Sci 107: 303-307, 2008.
27. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806, 2008.
28. 2+ store depletion in endothelial cells. Cell Calcium 43: 83-94, 2008.
29. Kaplin AI, Ferris CD, Voglmaier SM, Snyder SH. Purified reconstituted inositol 1,4,5-trisphosphate receptors. Thiol reagents act directly on receptor protein. J Biol Chem 269: 28972-28978, 1994.
30. 2+-exchanger in HCT116 human colon cancer cells. Arch Pharm Res 31: 54-59, 2008.
31. 2+ influx and the severity of acute pancreatitis. Gastroenterology 137: 1509-1517, 2009.
32. Lee MS, Kim YB, Lee SY, Kim JG, Kim SH, Ye SK, Lee JW. Integrin signaling and cell spreading mediated by phorbol 12-myristate 13-acetate treatment. J Cell Biochem 99: 88-95, 2006.
33. 2+ entry via NCX reversal in ATP stimulated smooth muscle cells. Biochem Biophys Res Commun 352: 130-134, 2007.
34. Lipskaia L, Hulot JS, Lompre AM. Role of sarco/endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation. Pflügers Arch 457: 673-685, 2009.
35. Loor R, Nowak NJ, Manzo ML, Douglass HO, Chu TM. Use of pancreas-specific antigen in immunodiagnosis of pancreatic cancer. Clin Lab Med 2: 567-578, 1982.
36. Ma HT, Venkatachalam K, Li HS, Montell C, Kurosaki T, Patterson RL, Gill DL. Assessment of the role of the inositol 1,4,5-trisphosphate receptor in the activation of transient receptor potential channels and store-operated Ca2+ entry channels. J Biol Chem 276: 18888-18896, 2001. (Pubitemid 33650577)
37. 2+ influx. Biochem J 397: 77-87, 2006.
38. Matter N, Ritz MF, Freyermuth S, Rogue P, Malviya AN. Stimulation of nuclear protein kinase C leads to phosphorylation of nuclear inositol 1,4,5-trisphosphate receptor and accelerated calcium release by inositol 1,4,5-trisphosphate from isolated rat liver nuclei. J Biol Chem 268: 732-736, 1993.
39. 2+ transport. Nat Rev Cancer 7: 519-530, 2007.
40. Mucsi I, Skorecki KL, Goldberg HJ. Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-beta1 on gene expression. J Biol Chem 271: 16567-16572, 1996. (Pubitemid 26239011)
41. Parekh AB, Putney JW Jr. Store-operated calcium channels. Physiol Rev 85: 757-810, 2005.
42. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 46: 5-27, 1996.
43. Peppiatt CM, Collins TJ, Mackenzie L, Conway SJ, Holmes AB, Bootman MD, Berridge MJ, Seo JT, Roderick HL. 2-Aminoethoxydiphenyl borate (2-APB) antagonises inositol 1,4,5-trisphosphate-induced calcium release, inhibits calcium pumps and has a use-dependent and slowly reversible action on store-operated calcium entry channels. Cell Calcium 34: 97-108, 2003.
44. 2+ entry in purinergically stimulated aorta smooth muscle cells. Circ Res 101: 1030-1038, 2007.
45. Putney JW Jr, Bird GS. The signal for capacitative calcium entry. Cell 75: 199-201, 1993.
46. 2+ exchanger in primary cardiac myofibroblast migration, contraction, and proliferation. J Cell Physiol 213: 540-551, 2007.
47. 2+ channel in intestinal epithelial cells and regulates early mucosal restitution after wounding. Am J Physiol Gastrointest Liver Physiol 290: G782-G792, 2006.
48. Sakaguchi M, Miyazaki M, Sonegawa H, Kashiwagi M, Ohba M, Kuroki T, Namba M, Huh NH. PKCalpha mediates TGFbeta-induced growth inhibition of human keratinocytes via phosphorylation of S100C/A11. J Cell Biol 164: 979-984, 2004.
49. Sakorafas GH, Tsiotou AG. Multi-step pancreatic carcinogenesis and its clinical implications. Eur J Surg Oncol 25: 562-565, 1999.
50. Sambrook JF. The involvement of calcium in transport of secretory proteins from the endoplasmic reticulum. Cell 61: 197-199, 1990.
51. Schmidt CM, Powell ES, Yiannoutsos CT, Howard TJ, Wiebke EA, Wiesenauer CA, Baumgardner JA, Cummings OW, Jacobson LE, Broadie TA, Canal DF, Goulet RJ Jr, Curie EA, Cardenes H, Watkins JM, Loehrer PJ, Lillemoe KD, Madura JA. Pancreaticoduodenectomy: a 20-year experience in 516 patients. Arch Surg 139: 718-725, 2004.
52. Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero RA Jr, Meltzer PS, Hahn SA, Kern SE. DPC4 gene in various tumor types. Cancer Res 56: 2527-2530, 1996.
53. Seymour AB, Hruban RH, Redston M, Caldas C, Powell SM, Kinzler KW, Yeo CJ, Kern SE. Allelotype of pancreatic adenocarcinoma. Cancer Res 54: 2761-2764, 1994.
54. 2+ exchange: molecular and pharmacological aspects. Circ Res 88: 864-876, 2001.
55. 2+ exchanger by calcineurin and protein kinase C. Ann NY Acad Sci 1099: 53-63, 2007.
56. 2+ exchangers 1 and 3 in human macrophages and monocytes. Eur J Immunol 39: 1405-1418, 2009.
57. Teasdale RD, Jackson MR. Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the golgi apparatus. Annu Rev Cell Dev Biol 12: 27-54, 1996. (Pubitemid 26422708)
58. Truty MJ, Urrutia R. Basics of TGF-beta and pancreatic cancer. Pancreatology 7: 423-435, 2007.
59. Venkatachalam K, Montell C. TRP channels. Annu Rev Biochem 76: 387-417, 2007.
60. Visser CJ, Bruggink AH, Korc M, Kobrin MS, de Weger RA, Seifert-Bock I, van Blokland WT, van Garderen-Hoetmer A, Woutersen RA. Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters. Carcinogenesis 17: 779-785, 1996.
61. 2+ in cultured human pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol 288: C245-C252, 2005.
62. Zhang YE. Non-Smad pathways in TGF-beta signaling. Cell Res 19: 128-139, 2009.
63. Zhuang L, Peng JB, Tou L, Takanaga H, Adam RM, Hediger MA, Freeman MR. Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies. Lab Invest 82: 1755-1764, 2002.